Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2025-04-09 Regulatory Filings
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
Rallis India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/04/2025 ,inter alia, to consider and approve the Audited Financial Results ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for April 23, 2025. The agenda includes approval of audited financial results for the quarter and financial year ended March 31, 2025, and recommendation of dividend for the financial year ended March 31, 2025. The letter references SEBI regulations related to disclosure and insider trading. The document does not contain any financial data or results itself but is an announcement of a future event where such results will be approved. The document length is short (1696 characters) and it serves as an intimation or notice rather than a report or detailed filing. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-04-09 English
Copy of Newspaper Publication
Regulatory Filings
2025-04-09 English
Pursuant to Reg. 30 read with Schedule III Para A of SEBI Listing Regulations we enclose the following documents: 1. Copy of circular letter dispatched on April 8, 2025 2. Copy of Newspaper ....
Regulatory Filings
2025-04-09 English
Enclosed is the specimen of letter sent to the shareholders whose shares are liable to be transferred to IEPF
Regulatory Filings
2025-04-08 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the transfer of shares to the Investor Education and Protection Fund (IEPF) due to unclaimed dividends. It references regulatory compliance under SEBI Listing Obligations and the Companies Act, and includes a specimen circular letter sent to shareholders. The document is short (2179 characters) and serves as an official notification or announcement rather than a detailed report or financial statement. It does not contain financial data, earnings, or management discussion. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit other specific categories.
2025-04-08 English
This is to certify that the details of securities dematerialised / rematerialised during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and Participants) ....
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, certifying details of securities dematerialised/rematerialised for the quarter ended March 31, 2025. It is addressed to depositories and stock exchanges and signed by the Company Secretary. The document is short (1225 characters) and serves as a compliance certification rather than a financial report or announcement of financial results. It does not contain financial statements or substantive financial data. It is primarily an officer certification letter related to regulatory compliance. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2025-04-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.